Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: A case report

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Poulin, Sébastien ^a   Corbeil, Claude ^b   Nguyen, Mélanie ^b   St Denis, Anik ^a   Côté, Lise ^c   Le Deist, Françoise ^d   Carignan, Alex ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b HÔPITAL CHARLES LEMOYNE   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acquired immunodeficiency; Atypical mycobacteria; Autoantibody; Cytomegalovirus; Interferon gamma; Mycobacterium colombiense

Indexed keywords

AMINE; AUTOANTIBODY; CIPROFLOXACIN; CLARITHROMYCIN; DORIPENEM; ETHAMBUTOL; GAMMA INTERFERON ANTIBODY; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; STAT1 PROTEIN; TOBRAMYCIN; VANCOMYCIN;

ADD ON THERAPY; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BRONCHUS TUMOR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOMEGALOVIRUS INFECTION; DEATH; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; LUNG HILUS; LYMPHADENOPATHY; MEDIASTINITIS; MEDIASTINUM LYMPHADENOPATHY; MIXED INFECTION; MULTIPLE ORGAN FAILURE; MYCOBACTERIOSIS; MYCOBACTERIUM COLOMBIENSE INFECTION; PERSISTENT INFECTION; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECURRENT INFECTION; RISK FACTOR; SALMONELLOSIS; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS PNEUMONIA; WEIGHT REDUCTION;

AUTOANTIBODIES; COINFECTION; CYTOMEGALOVIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON-GAMMA; MIDDLE AGED; MYCOBACTERIUM INFECTIONS;

EID: 84872448576     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-24     Document Type: Article

References (20)

1. Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature. Infection 2011, 39:65-71. 10.1007/s15010-010-0067-3, 21128092.
2. Picque JB, Blot M, Binois R, Jeudy G, Simonet AL, Cagnon J, Mahy S, Duong M, Buisson M, Chavanet P, Piroth L. [Recurrent non tuberculous mycobacterial infections: think about anti-interferon-gamma autoantibodies!]. Rev Med Interne 2012, 33:103-106. 10.1016/j.revmed.2011.11.012, 22236500.
3. van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009, 9:688-698. 10.1016/S1473-3099(09)70255-5, 19850227.
4. Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, Longhurst HJ, Kumararatne DS. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004, 38:e10-e14. 10.1086/380453, 14679469.
5. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K. Subcommittee ATSMD, American Thoracic S,Infectious Disease Society of A: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416. 10.1164/rccm.200604-571ST, 17277290.
6. Clinical and Laboratory Standards Institute (CLSI) Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard- Second 2012, Clinical and Laboratory Standards Institute, Wayne, PA, USA, M24-A2, 124825, 9431938, Clinical and Laboratory Standards Institute (CLSI).
7. Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, Pancholi MJ, Yang LM, Priel DL, Uzel G, Freeman AF, Hayes CE, Baxter R, Cohen SH, Holland SM. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood 2012, 119:3933-3939. 10.1182/blood-2011-12-395707, 22403254.
8. Tang BS, Chan JF, Chen M, Tsang OT, Mok MY, Lai RW, Lee R, Que TL, Tse H, Li IW, To KK, Cheng VC, Chan EY, Zheng B, Yuen KY. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol 2010, 17:1132-1138. 10.1128/CVI.00053-10, 2897261, 20445006.
9. Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012, 367:725-734. 10.1056/NEJMoa1111160, 22913682.
10. Doffinger R, Patel S, Kumararatne DS. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr Opin Rheumatol 2005, 17:440-446. 10.1097/01.bor.0000166387.70475.dd, 15956841.
11. Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 2008, 31:1322-1333. 10.1183/09031936.00140007, 18515557.
12. Murcia MI, Tortoli E, Menendez MC, Palenque E, Garcia MJ. Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant. Int J Syst Evol Microbiol 2006, 56:2049-2054. 10.1099/ijs.0.64190-0, 16957098.
13. Esparcia O, Navarro F, Quer M, Coll P. Lymphadenopathy caused by Mycobacterium colombiense. J Clin Microbiol 2008, 46:1885-1887. 10.1128/JCM.01441-07, 2395067, 18305134.
14. Despierres L, Cohen-Bacrie S, Richet H, Drancourt M. Diversity of Mycobacterium avium subsp. hominissuis mycobacteria causing lymphadenitis, France. Eur J Clin Microbiol Infect Dis 2012, 31:1373-1379. 10.1007/s10096-011-1452-2, 22042560.
15. Vuorenmaa K, Ben Salah I, Barlogis V, Chambost H, Drancourt M. Mycobacterium colombiense and pseudotuberculous lymphadenopathy. Emerg Infect Dis 2009, 15:619-620. 10.3201/eid1504.081436, 2671429, 19331753.
16. Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, Martyak LA, Kubak B, Holland SM. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005, 175:4769-4776.
17. Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol 2008, 61:1006-1012. 10.1136/jcp.2007.051201, 18326015.
18. Revoltella RP. Natural and therapeutically-induced antibodies to cytokines. Biotherapy 1998, 10:321-331. 10.1007/BF02678552, 9592020.
19. Browne SK, Holland SM. Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol 2010, 10:534-541. 10.1097/ACI.0b013e3283402b41, 3132574, 20966748.
20. Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke WD, Grutz G, Meisel C, Halle E, Gobel UB, Volk HD, Suttorp N. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004, 103:673-675. 10.1182/blood-2003-04-1065, 12947000.